MADRIGAL PHARMACEUTICALS INC's ticker is MDGL and the CUSIP is 558868105. A total of 142 filers reported holding MADRIGAL PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 1.87 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,137,961 | -29.5% | 21,487 | +11.4% | 0.01% | -28.6% |
| Q2 2023 | $4,453,911 | +801.6% | 19,281 | +153.7% | 0.01% | +600.0% |
| Q3 2022 | $494,000 | -68.8% | 7,600 | -59.4% | 0.00% | -60.0% |
| Q4 2021 | $1,585,000 | +6.2% | 18,700 | 0.0% | 0.01% | 0.0% |
| Q3 2021 | $1,492,000 | -18.1% | 18,700 | 0.0% | 0.01% | -16.7% |
| Q2 2021 | $1,822,000 | +10.5% | 18,700 | +32.6% | 0.01% | -14.3% |
| Q1 2021 | $1,649,000 | -58.7% | 14,100 | -55.7% | 0.01% | -53.3% |
| Q1 2019 | $3,990,000 | -42.0% | 31,848 | -47.8% | 0.02% | -51.6% |
| Q4 2018 | $6,883,000 | -2.9% | 61,056 | +84.3% | 0.03% | +19.2% |
| Q3 2018 | $7,091,000 | +17.3% | 33,122 | +53.2% | 0.03% | +4.0% |
| Q2 2018 | $6,047,000 | – | 21,619 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HealthCor Management, L.P. | 902,601 | $100,342,000 | 3.87% |
| L1 Capital Pty Ltd | 113,464 | $12,608,000 | 2.35% |
| Avoro Capital Advisors LLC | 1,225,000 | $136,183,000 | 2.34% |
| Tao Capital Management LP | 51,396 | $5,714,000 | 1.40% |
| ARMISTICE CAPITAL, LLC | 316,000 | $35,130,000 | 1.20% |
| ACUTA CAPITAL PARTNERS, LLC | 32,500 | $3,613,000 | 0.98% |
| Capital Impact Advisors, LLC | 24,351 | $2,707,000 | 0.66% |
| Baker Brothers Advisors | 1,499,213 | $166,668,000 | 0.63% |
| Rock Springs Capital Management LP | 256,768 | $28,545,000 | 0.60% |
| SHIKIAR ASSET MANAGEMENT INC | 12,000 | $1,334,000 | 0.48% |